Desq Long
Sign in
SEC FORM 4
—

Xenon Pharmaceuticals Inc. (XENE)

Acquisition (code M) of 7,500 shares; price not stated (see filing).

Reporting Person Kelly Thomas Patrick · Officer Title Chief Financial Officer · Transaction Code M

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001193125-26-424428 · filed 2026-10-16 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Xenon Pharmaceuticals Inc. (XENE)." Disclosed 2026-10-16. https://desqlong.com/cards/0001193125-26-424428-1 (retrieved 2026-10-17).